Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AgfiledCriticalSchering Ag
Publication of CR7380ApublicationCriticalpatent/CR7380A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Medicinal Preparation
(AREA)
Abstract
Se refiere a una formulacion para comprimidos de liberacion rapida con > 99,19 de fludara puro (Fludara purisimo) como ingrediente activo en una composicion definida en las impurezas residuales.It refers to a formulation for rapid-release tablets with> 99.19 pure fludara (Fludara purisimo) as an active ingredient in a composition defined in residual impurities.
CR7380A2001-12-202004-06-24
ORAL FORMULATION OF FLUDARA PURISIMO WITH QUICK RELEASE OF ACTIVE INGREDIENT
CR7380A
(en)
COMBINATION OF (A) AT LEAST A 2,5-DIHYDROBENCENOSULPHONIC DERIVATIVE, AS CALCIUM DOBEYLATE, ETHAMSYLATE AND PERSILATE, AND (B) AT LEAST A MODULATOR OF POTASSIUM CHANNELS, PHARMACEUTICAL COMPOSITION CONTAINING AND USE AS A MEDICATION IN PROFILA